Jeffrey Haynes, PA
Surgical · Las Vegas, NVNPI 1568706539
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.1% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,755 and has fallen 61.6% since, to $1,059 in 2025. Among surgical clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 244 payments — averaging $33.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Biohaven Pharmaceuticals, Inc.$960
- AbbVie$934
- Forte Bio-pharma LLC$764
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$615
- Medtronic$370
- plus $3K from 24 others
What the payments were for
- Consulting fees$80010%
- Food & beverage$7,31290%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 53 | $1,851 |
| Biohaven Pharmaceuticals, Inc. | 4 | $960 |
| AbbVie | 37 | $934 |
| Forte Bio-pharma LLC | 13 | $764 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 25 | $615 |
| Medtronic | 4 | $370 |
| Scilex Pharmaceuticals Inc. | 23 | $307 |
| Saluda Medical Americas, Inc. | 6 | $255 |
| Amgen | 11 | $241 |
| Redhill Biopharma Inc. | 10 | $215 |
| GRT US Holding, Inc. | 5 | $178 |
| Collegium Pharmaceutical, Inc. | 10 | $171 |
| Biotronik NRO, Inc. | 4 | $167 |
| Globus Medical | 2 | $156 |
| Pfizer | 8 | $156 |
| Vertex | 1 | $125 |
| Relievant Medsystems, Inc. | 1 | $113 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $86 |
| Lundbeck LLC | 2 | $63 |
| Lilly USA, LLC | 4 | $60 |
| Arbor Pharmaceuticals, Inc. | 4 | $59 |
| SPR Therapeutics, Inc | 2 | $42 |
| Azurity Pharmaceuticals, Inc. | 2 | $35 |
| Averitas Pharma Inc. | 1 | $32 |
| Tonix Medicines, Inc. | 1 | $32 |
| Merz Pharmaceuticals, LLC | 1 | $32 |
| Biodelivery Sciences International, Inc. | 2 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $28 |
| Nalu Medical, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolate$1,288
- NURTEC ODT$925
- Nalocet$536
- GENERAL PAIN MANAGEMENT$531
- UBRELVY$378
- INTELLIS ADAPTIVESTIM$302
- QULIPTA$257
- RELISTOR$241
- Intracept$226
- WaveWriter Alpha Prime 16$149
- Evoke SCS$143
- Senza$139
- Qutenza$118
- SUPERION$116
How this compares
$8,112 in reported general payments places this provider in the 90th percentile of 91 surgical providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 413 | $108,320 |
| Diclofenac Sodium | 108 | $28,691 |
| OxycontinOxycodone Hcl | 26 | $26,611 |
| BelbucaBuprenorphine Hcl | 24 | $25,028 |
| Emgality PenGalcanezumab-Gnlm | 33 | $23,187 |
| UbrelvyUbrogepant | 23 | $20,134 |
| Nurtec OdtRimegepant Sulfate | 14 | $17,075 |
| Oxycodone Hcl | 368 | $13,179 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 324 | $10,443 |
| MovantikNaloxegol Oxalate | 24 | $9,421 |
| Buprenorphine | 16 | $4,743 |
| Gabapentin | 289 | $3,681 |
| Morphine Sulfate ErMorphine Sulfate | 128 | $3,254 |
| Ondansetron OdtOndansetron | 46 | $2,400 |
| Pregabalin | 134 | $1,903 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $171 | $25,02824 claims |
| AbbVieUbrelvy | $934 | $20,13423 claims |
| PfizerNurtec Odt | $156 | $17,07514 claims |
| Redhill Biopharma Inc.Movantik | $215 | $9,42124 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 91 surgical providers in Nevada.
Other surgical in Las Vegas
- Heather RohrerLas Vegas$253K
- Andrea EghterafiLas Vegas$11K
- Kasie PalmerLas Vegas$8K
- Darin DutsonLas Vegas$8K
- Anastasia van LeuvenLas Vegas$6K
- Edmund Afrim-AntwiLas Vegas$4K
- Milan PatelLas Vegas$4K
- Heather TaLas Vegas$3K
- Sherry HallLas Vegas$3K
- Angelie TengLas Vegas$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.